TrialClinical pharmacology and therapeutics2026

Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis.

Joachim Almquist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.